Journal
IN VIVO
Volume 34, Issue 5, Pages 2469-2474Publisher
INT INST ANTICANCER RESEARCH
DOI: 10.21873/invivo.12062
Keywords
Demethoxycurcumin; DMC; human cervical cancer; HeLa cells; xenograft mice
Categories
Funding
- Ministry of Science and Technology, Taipei, Taiwan [MOST 107-2635-B-468-002 -]
- China Medical University Hospital [DMR-108-108]
Ask authors/readers for more resources
Background/Aim: Demethoxycurcumin (DMC), a derivate of curcumin from natural plants, exerts antitumor effects on various human cancer cells in vitro and in vivo. Nevertheless, no reports have disclosed whether DMC can affect the growth of human cervical cancer cells in vivo. Therefore we investigated the antitumor effects of DMC on a HeLa cell xenograft model in nude mice in this study. Materials and Methods: Twenty-four nude mice were subcutaneously injected with HeLa cells. All mice were randomly divided into control, low-dose DMC (30 mg/kg), and high-dose DMC (50 mg/kg) groups and individual mice were treated intraperitoneally accordingly every 2 days. Results: DMC significantly reduced tumor weights and volumes of HeLa cell xenografts in mice, indicating the suppression of growth of xenograft tumors. Conclusion: These effects and findings might provide evidence for investigating the potential use of DMC as an anti-cervical cancer drug in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available